ALK and neoplasm: Furthermore, next-generation sequencing (NGS) of a 425-gene panel (ALK, EGFR, RET, MET, KRAS, etc.)was conducted to identify the patient’s mutated genes, microsatellite instability (MSI), and tumor mutational burden (TMB).